Virtual Medicinal Product (VMP)
-
Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted) powder and suspension for suspension for injection 0.5ml vials
Name Details
|
Current Name
Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted) powder and suspension for suspension for injection 0.5ml vials
|
Start Date
06-09-2023
|
End Date
|
|
|
Abbreviated Name
RSV vaccine (recombinant, adjuvanted) inj 0.5ml vials
|
Start Date
06-09-2023
|
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 0.5
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular
- Form
- Powder and solvent for suspension for injection
- Ontology Form/Route
- suspensioninjection.intramuscular
- Name Basis
- Other
Codes
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 42237011000001102 |
06-09-2023 |
|
VMP Ingredients
Name
Respiratory Syncytial Virus recombinant glycoprotein F (RSVPreF3) antigen
Basis of strength description
BOSS
Strength and UOM (Nmr)
Strength and UOM (Dmr)
Virtual Medicinal Product Pack (VMPP) Information